Current Mounjaro Pricing Before September Increases
September Price Rise Alert - Order Now
Industry-wide Mounjaro price increases are scheduled for September, making current stock particularly valuable. EverydayMeds has secured full inventory of all doses at pre-increase rates, allowing patients to begin treatment before costs rise. Our prescription-only tirzepatide supply includes starter doses through to maintenance strengths, all available for immediate clinical assessment and dispatch.
All Doses Currently In Stock
Single pen pricing remains at current levels: 2.5mg starter dose £169.99 (£129.99 first order), progressing through 5mg £199.99, 7.5mg £249.99, 10mg £269.99, 12.5mg £299.99, to maximum 15mg £318.99. First-time patients save £40 with FIRST40, whilst returning customers receive £25 discount on every order. Bundle options provide additional value with our Intro Duo combining 2.5mg and 5mg pens for £339.99 first order.
Reliable UK Supply Chain
Our GPhC-registered pharmacy maintains direct supplier relationships ensuring consistent Mounjaro availability. Unlike supply shortages affecting other providers, EverydayMeds' established procurement means patients can rely on continuous treatment without interruption. This prescription-only medicine requires clinical assessment, available through standard 3-day or express 24-hour approval.
Beat Price Rises with Bundle Savings
Multi-pen bundles offer maximum protection against September increases. Progress Trio bundle (5mg, 7.5mg, 10mg) at £674.99 covers typical dose escalation periods, whilst Advance Duo (7.5mg + 10mg) at £489.99 suits patients transitioning to maintenance doses. These bundles lock in current pricing for extended treatment periods.
Order Before Stocks Reduce
Current inventory levels support immediate dispatch, but September price adjustments may affect availability as demand increases. Patients beginning Mounjaro treatment benefit from starting now at current rates, with the prescription-only injectable designed to support weight management alongside reduced-calorie diet and increased physical activity. Express approval ensures rapid treatment commencement.
